NCT05148624

Brief Summary

Bed rest after embryo transfer (ET) has been clinically advised without robust scientific evidence. In investigators' unit, post ET instructions are given immediately after ET to sub-fertile women while lying in bed. The aim of the study is to compare the reproductive outcome of this practice compared with immediate ambulation and giving instructions after emptying the bladder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 28, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 8, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2024

Completed
Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

2.6 years

First QC Date

October 15, 2021

Last Update Submit

June 28, 2024

Conditions

Keywords

Embryo transferBed restClinical pregnancyMiscarriageOngoing pregnancy

Outcome Measures

Primary Outcomes (1)

  • Percentage of participants who received or did not receive bed rest after embryo transfer who carried a viable pregnancy beyond 10 weeks' gestation

    Ongoing pregnancy will be defined as a viable pregnancy detected by ultrasound examination between 10 - 13 weeks' gestation. The two groups will be compared using relative risk with 95% confidence interval.

    14 weeks

Secondary Outcomes (2)

  • Percentage of participants who received or did not receive bed rest after embryo transfer who carried a viable pregnancy beyond 6 weeks' gestation

    6 weeks

  • Percentage of participants who received or did not receive bed rest after embryo transfer who aborted before 12 weeks' gestation

    12 weeks

Study Arms (2)

Immediate ambulation

EXPERIMENTAL

Sub-infertile women will immediately ambulate and empty her bladder after embryo transfer.

Procedure: embryo transfer

short time bed rest

ACTIVE COMPARATOR

Sub-infertile women will stay in the bed (same bed where embryo transfer was performed) after embryo transfer for a period of 5 minutes without emptying her bladder.

Procedure: embryo transfer

Interventions

immediate ambulation after embryo transfer

Immediate ambulationshort time bed rest

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen in reproductive age group who underwent embryo transfer
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Couple undergoing In vitro fertilization, Intracytoplasmic sperm injection, Frozen embryo replacement or Frozen Intracytoplasmic sperm injection
  • Age between 20 to 40-year-old
  • Couples who are willingly accepting to participate in the study. Both husband and wife will sign the consent.

You may not qualify if:

  • Women with diminished ovarian reserve (AMH \< 1.2 ng/ml or AFC \< 7)
  • Women with unilateral or bilateral hydro salpinx
  • Women with bilateral endometriomas
  • Women with adenomyosis
  • Women with large (more than 3 cm uterine fibroid)
  • Women with fluid or polyp in the uterine cavity
  • Women with known chronic endometritis
  • Women with H/O recurrent \>2 pregnancy loss or implantation failure
  • Were enrolled in this study before

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dubai Fertility Center

Dubai, 8729, United Arab Emirates

Location

MeSH Terms

Conditions

Infertility, FemaleAbortion, Spontaneous

Interventions

Embryo Transfer

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertilityPregnancy Complications

Intervention Hierarchy (Ancestors)

Reproductive Techniques, AssistedReproductive TechniquesTherapeuticsInvestigative Techniques

Study Officials

  • Priya Cherian

    Dubai Fertility Center - Dubai Health Authority

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Obs Gyn and reproductive medicine - Head of Medical Affair

Study Record Dates

First Submitted

October 15, 2021

First Posted

December 8, 2021

Study Start

July 28, 2021

Primary Completion

March 20, 2024

Study Completion

June 27, 2024

Last Updated

July 1, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations